Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
113 studies found for:    "Motor neuro-ophthalmic disorders"
Show Display Options
Download search resultsDownload the search results for:
"Motor neuro-ophthalmic disorders" (113 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Evaluation and Treatment of Pediatric Eye Diseases
Condition: Ocular Motility Disorder
Intervention: Procedure: current standard of care treatments
2 Enrolling by invitation Frontoparietal Priority Maps as Biomarkers for MTBI
Conditions: TBI (Traumatic Brain Injury);   Ocular Motility Disorders
Intervention:
3 Recruiting Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency
Condition: Convergence Insufficiency
Intervention: Procedure: Office-based vergence/accommodative therapy
4 Recruiting Convergence Insufficiency Treatment Study (CITS)
Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy;   Procedure: Near target push-ups;   Other: Placebo home-based computer vergence/accommodative therapy;   Procedure: Placebo yoked prism flippers
5 Completed Surgery and Convergence Insufficiency Intermittent Exotropia
Condition: Complications
Interventions: Procedure: Post exercise Surgery;   Procedure: Orthoptics;   Procedure: Postop orthoptics;   Procedure: Post exercises surgery
6 Completed Study of Eyes and Attention Deficit (SEAD)
Conditions: ADHD;   Convergence Insufficiency;   Accommodative Insufficiency
Intervention:
7 Unknown  Convergence Insufficiency Treatment Trial (CITT)
Conditions: Convergence Insufficiency;   Binocular Vision Disorder
Interventions: Behavioral: Home-based Pencil Push-Up Therapy;   Behavioral: Home-based Pencil Push-ups with Computer Vision Therapy/Orthoptics;   Behavioral: Office-based Vision Therapy/Orthoptics;   Behavioral: Placebo Office-based Vision Therapy/Orthoptics
8 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
9 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab
10 Completed A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children
Condition: Convergence Insufficiency
Interventions: Procedure: Base-in prism glasses for reading;   Procedure: Placebo reading glasses
11 Completed Randomized Trial of Treatments for Convergence Insufficiency
Condition: Convergence Insufficiency
Interventions: Procedure: Pencil Push-ups;   Procedure: Office-based Vision Therapy;   Procedure: Placebo Office-based Vision Therapy
12 Completed Eye Teaming Evaluation Study
Condition: Convergence Insufficiency
Intervention: Device: NPC targets
13 Unknown  Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Parkinsonian Syndrome;   Multiple System Atrophy;   Supranuclear Palsy, Progressive;   Essential Tremor;   Vascular Parkinsonism;   Drug Induced Parkinsonism
Intervention:
14 Completed Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: tideglusib;   Drug: placebo
15 Recruiting Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders, PD,Essential Tremor, (ET),Cortical Basal Degeneration, (CBD),Multiple Systems Atrophy (MSA), Magnetoencephalography
Conditions: Essential Tremor;   Multiple System Atrophy;   Corticobasal Degeneration;   Supranuclear Palsy, Progressive
Intervention:
16 Recruiting 4 Repeat Tauopathy Neuroimaging Initiative
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Other: Observational Study
17 Completed Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: Davunetide;   Drug: Placebo
18 Available Expanded Access Study of Amifampridine Phosphate in LEMS, Congenital Myasthenic Syndrome, or Downbeat Nystagmus Patients
Conditions: Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
Intervention: Drug: Amifampridine Phosphate
19 Not yet recruiting Study of the Neural Basis of Analogical Reasoning
Conditions: Frontotemporal Dementia;   Progressive Supranuclear Palsy;   Healthy Subjects
Interventions: Device: transcranial magnetic stimulation;   Other: MRI imaging;   Other: EEG recording;   Behavioral: Neuropsychological examination
20 Recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP)
Interventions: Drug: TPI 287  2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years